Key Statistics for 587
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (HKD) (ttm)
|Est. EPS (HKD) (06/2013)
|Est. PEG Ratio
|Market Cap (M HKD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (HKD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 587
- Net Income (M/HKD)
Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.
More Company Profile & Key Executives for 587
|Zhang Y "Peter"Chairman/Co-Founder||Deng JieCEO/Co-Founder|
|Niu YiChief Inspector:HR||Long Xian FengExec Dir/Gen Mgr|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries